Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The faecal extraction systems market is witnessing steady expansion, driven by growing healthcare needs and advancements in diagnostic technologies. As awareness about gastrointestinal health increases, this sector is expected to see continued growth, supported by innovations and rising adoption of advanced testing methods. Let’s explore the current market landscape, its key growth drivers, emerging trends, major players, and segment performance.

Market Size and Growth Trajectory of the Faecal Extraction Systems Market

The market for faecal extraction systems has experienced notable growth, increasing from $1.7 billion in 2025 to $1.79 billion in 2026, representing a compound annual growth rate (CAGR) of 5.5%. This upward trend during the past years is attributed to factors such as a higher incidence of gastrointestinal infections, expansion in diagnostic laboratory infrastructure, broader use of fecal biomarker testing, growth in parasite screening efforts, and improved clinical understanding of gut health. Looking ahead, the market is projected to reach $2.21 billion by 2030, maintaining a CAGR of 5.4%. This forecasted growth is fueled by rising demand for early detection of diseases, increased investments in sophisticated diagnostic assays, expansion of outpatient diagnostic services, growing preventive healthcare focus, and greater adoption of automated laboratory processes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8297&type=smp

Key Influences Fueling Growth in the Faecal Extraction Systems Market

An important factor driving market expansion is the rising prevalence of inflammatory bowel disease (IBD). IBD encompasses chronic conditions characterized by inflammation within the digestive tract. Faecal extraction systems play a critical role in diagnosing, monitoring disease progression, guiding treatment plans, and predicting relapse or post-surgical recurrence in IBD patients. Consequently, as the number of people affected by IBD increases, so does the demand for these systems. For instance, a report published in September 2023 by the IBD Clinical and Research Centre in Canada highlights that over 320,000 Canadians currently live with IBD, with a prevalence rate of 825 per 100,000 individuals. This figure is expected to rise annually by 2.44%, potentially reaching 470,000 people or 1.1% of the population by 2035. This growing patient base is a significant impetus for market growth.

Additional Factors Boosting Market Demand

Besides IBD prevalence, the faecal extraction systems market benefits from innovations enhancing diagnostic accuracy and hygiene. Increasing emphasis on early disease screening, particularly for colorectal cancer and parasitic infections, also supports market momentum. Furthermore, expanding healthcare infrastructure and rising awareness about gut health contribute to sustained demand. The integration of automated workflows in laboratories further streamlines testing processes, making faecal extraction systems more efficient and accessible.

Access The Complete Faecal Extraction Systems Market Report:

https://www.thebusinessresearchcompany.com/report/faecal-extraction-systems-global-market-report

Breakdown of the Faecal Extraction Systems Market Segmentation

This market is analyzed across several key segments:

1) Assay Type: Calprotectin and Hemoglobin assays

2) Analysis Test Method: Microscopic, Chemical, Immunological, and Microbiological tests

3) Indications: Parasitic infections, bacterial indications, and poor nutrient absorption

4) End-Use Settings: Diagnostic centers, hospitals, and clinics

Further classification includes:

– Calprotectin assays subdivided into quantitative and qualitative types

– Hemoglobin tests broken down into Fecal Occult Blood Tests (FOBT) and Immunochemical Fecal Hemoglobin Tests

Innovative Trends Shaping the Faecal Extraction Systems Market

Market players are focusing on developing cutting-edge products such as colorectal cancer (CRC) screening tests to broaden their customer base and increase revenues. CRC screening tests aim to detect colorectal cancer or its precursors in asymptomatic individuals. For example, in November 2023, US-based diagnostics company Guardant Health introduced Shield, a blood-based colorectal cancer screening assay. This test stands out by identifying unique DNA markers associated with cancer presence. Its effectiveness was validated in the ECLIPSE registrational study, which enrolled over 20,000 participants across the United States, demonstrating Shield’s potential as a non-invasive and reliable screening tool.

Competitive Landscape and Leading Companies in the Faecal Extraction Systems Market

Several key companies dominate this market, including Alpha Laboratories Ltd., Arbor Assays, Buhlmann Laboratories AG, Calpro AS, DRG Instruments GmbH, Biohit Healthcare Ltd., Meridian Bioscience Inc., Quidel Corporation, DiaSorin SpA, Sekisui Diagnostics LLC, Abbott Laboratories, Roche Diagnostics Corporation, Randox Laboratories Ltd., Trinity Biotech plc, bioMérieux SA, Werfen SA, Mobidiag Oy, Hologic Inc., Siemens Healthineers, Beckman Coulter Inc., and Thermo Fisher Scientific Inc. These industry leaders continuously innovate to maintain competitiveness and meet evolving diagnostic needs.

Regional Market Leadership and Growth Patterns

In 2025, North America held the largest share of the faecal extraction systems market. However, the report also covers other significant regions, including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, highlighting a comprehensive global market perspective. The Asia-Pacific region is anticipated to witness the fastest growth in the coming years, driven by expanding healthcare infrastructure and increasing awareness of gastrointestinal diseases.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model